Gastrointestinal Adverse Events with Sodium Polystyrene Sulfonate (Kayexalate) Use: A Systematic Review

2013/01/12 by Ziv Harel, Shai Har-El, Shai Harel +4 · 26 citations
Medicine · #Potassium and Related Disorders #Poisoning and overdose treatments #Renal function and acid-base balance

paper · doi:10.1016/j.amjmed.2012.08.016

Cited by

• Treatment of hyperkalemia: something old, something new
• Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia. [europepmc]
• Colon Necrosis Due to Sodium Polystyrene Sulfonate with and without Sorbitol: An Experimental Study in Rats. [europepmc]
• Potassium and Its Discontents: New Insight, New Treatments. [europepmc]
• Optimal Dose and Method of Administration of Intravenous Insulin in the Management of Emergency Hyperkalemia: A Systematic Review. [europepmc]
• Updates in hyperkalemia: Outcomes and therapeutic strategies. [europepmc]
• Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia. [europepmc]
• Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk. [europepmc]
• Revisiting RAAS blockade in CKD with newer potassium-binding drugs. [europepmc]
• Chronic Kidney Disease and Dietary Measures to Improve Outcomes. [europepmc]
• New options for the management of chronic hyperkalemia. [europepmc]
• Management of hyperkalemia in the acutely ill patient. [europepmc]
• Current treatment and unmet needs of hyperkalaemia in the emergency department. [europepmc]
• Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England. [europepmc]
• Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study. [europepmc]
• Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. [europepmc]
• A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia. [europepmc]
• Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease. [europepmc]
• Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan. [europepmc]
• Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trials. [europepmc]
• Ambulatory Treatments for RAAS Inhibitor-Related Hyperkalemia and the 1-Year Risk of Recurrence. [europepmc]
• Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patients. [europepmc]
• Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-Analysis. [europepmc]
• Assessment of Patiromer Monotherapy for Hyperkalemia in an Acute Care Setting. [europepmc]
• Layer-by-Layer Cell Encapsulation for Drug Delivery: The History, Technique Basis, and Applications. [europepmc]
• Hyperkalemia: Prevalence, Predictors and Emerging Treatments. [europepmc]